Biogen (BIIB) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wall Street Today: Market Ends Wild Political TV Day in the Green
Kevin Travers15:38 ET
Biogen, Eisai Alzheimer's Drug Sent Back for EU Nod After Safety Review
Seeking AlphaFeb 28 09:06 ET
The CHMP Reaffirms Positive Opinion For Lecanemab In Early Alzheimer's Disease
BenzingaFeb 28 08:23 ET
Express News | EMA Says Chmp: Concluded That Its Opinion Recommending Marketing Authorisation for Leqembi (Lecanemab) Does Not Need to Be Updated
ReutersFeb 28 07:37 ET
Wall Street Today: Market Decides Down is the Direction
Kevin TraversFeb 27 16:01 ET
Live Stock News: Nvidia Does not run Things Around here Anymore
Kevin TraversFeb 27 11:06 ET

Comments

thoughtful Bat_8163

Feb 12 08:41

$Biogen (BIIB.US)$ Leqembi sale 81 m, last quarter was 51 m. more than 50% higher. Third quarter (51m) was 30% higher than the second. Even though it is just a small percentage of the total revenue (2.46 billion), the sale of Leqembinis is accelerating

3

Moomoo News Global

Feb 5 07:04

Columns Tariff Investment Opportunities: Four Sectors as Potential Safe Havens

Over the weekend, President Donald Trump announced tariffs on the U.S.'s top three trading partners—Canada, Mexico, and China—and threatened similar measures against the EU. On Monday, U.S. stocks experienced a selloff, with the major indices dropping. Losses narrowed, however, after news broke of a delay in imposing tariffs on Mexico.
Market worries over the tariffs focus on two key issues. U.S. companies that depend heavily ...

44

4

94

Stock_Drift

Jan 26 19:58

$Biogen (BIIB.US)$

US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug

ColdJoke

Jan 23 08:17

massive layoff

$Biogen (BIIB.US)$ They have massive layoff on R&D side from social networking information. Middle term positive to stock price and shareholders. Source mentions like 50% cut in USA R&D, some teams are wiped out.

2